JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201000200 on March 5, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16456-16463, May 10, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16456    most recent
M201000200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radons, J.
Right arrow Articles by Falk, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radons, J.
Right arrow Articles by Falk, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Essential Regions in the Cytoplasmic Tail of Interleukin-1 Receptor Accessory Protein Critical for Interleukin-1 Signaling*

Jürgen RadonsDagger §, Stefan GablerDagger , Holger Wesche, Christian KorherrDagger ||, Robert HofmeisterDagger **, and Werner FalkDagger

From the Dagger  Klinik und Poliklinik für Innere Medizin I, Universität Regensburg, D-93042 Regensburg, Germany and  Tularik Inc., South San Francisco, California 94080

Interleukin (IL)-1 plays an important role in inflammation and regulation of immune responses. The activated IL-1 receptor complex, which consists of the IL-1 receptor type I and the IL-1 receptor accessory protein (IL-1RAcP), generates multiple cellular responses including NF-kappa B activation, IL-2 secretion, and IL-2 promoter activation. Reconstitution experiments in EL4D6/76 cells lacking IL-1RAcP expression and IL-1 responsiveness were used to analyze structure-function relationships of the IL-1RAcP cytoplasmic tail. Mutating a potential tyrosine kinase phosphorylation motif and various conserved amino acid (aa) residues had no effect on IL-1 responsiveness. Truncation analyses revealed that box 3 of the TIR domain was required for NF-kappa B activation, IL-2 production, and c-Jun N-terminal kinase (JNK) activation, whereas IL-2 promoter activation was only partially inhibited. Surprisingly, deletion of aa 527-534 resulted in almost complete loss of all IL-1 responsiveness. Replacement of these aa with alanyl residues did not reconstitute NF-kappa B activation, IL-2 production, or JNK activation but partly restored IL-2 promoter activation. Immunoprecipitation data revealed a strong correlation between MyD88 binding with NF-kappa B activation and IL-2 production but not with IL-2 promoter activation. Taken together, our data indicate that box 3 of IL-1RAcP is critical for IL-1-dependent NF-kappa B activation and stabilization of IL-2 mRNA via JNK, whereas aa 527-534 largely contribute to IL-2 promoter activation.


* This work was supported by grants from the Deutsche Forschungsgemeinschaft and by European Community Grant BIO4-CT97-2107 (to W. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Klinik und Poliklinik für Innere Medizin I, Universität Regensburg, D-93042 Regensburg, Germany. E-mail: juergen.radons@klinik.uni-regensburg.de.

|| Present address: Xantos Biomedicine AG, D-82152 Martinsried, Germany.

** Present address: Micromet GmbH, D-82152 Martinsried, Germany.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Ali, M. Huber, C. Kollewe, S. C. Bischoff, W. Falk, and M. U. Martin
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells
PNAS, November 20, 2007; 104(47): 18660 - 18665.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. Brikos, R. Wait, S. Begum, L. A. J. O'Neill, and J. Saklatvala
Mass Spectrometric Analysis of the Endogenous Type I Interleukin-1 (IL-1) Receptor Signaling Complex Formed after IL-1 Binding Identifies IL-1RAcP, MyD88, and IRAK-4 as the Stable Components
Mol. Cell. Proteomics, September 1, 2007; 6(9): 1551 - 1559.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Li, J. Zienkiewicz, and J. Hawiger
Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1{beta} Signaling Pathway
J. Biol. Chem., July 15, 2005; 280(28): 26152 - 26159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Loiarro, C. Sette, G. Gallo, A. Ciacci, N. Fanto, D. Mastroianni, P. Carminati, and V. Ruggiero
Peptide-mediated Interference of TIR Domain Dimerization in MyD88 Inhibits Interleukin-1-dependent Activation of NF-{kappa}B
J. Biol. Chem., April 22, 2005; 280(16): 15809 - 15814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Towne, K. E. Garka, B. R. Renshaw, G. D. Virca, and J. E. Sims
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-{kappa}B and MAPKs
J. Biol. Chem., April 2, 2004; 279(14): 13677 - 13688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Radons, S. Dove, D. Neumann, R. Altmann, A. Botzki, M. U. Martin, and W. Falk
The Interleukin 1 (IL-1) Receptor Accessory Protein Toll/IL-1 Receptor Domain: ANALYSIS OF PUTATIVE INTERACTION SITES BY IN VITRO MUTAGENESIS AND MOLECULAR MODELING
J. Biol. Chem., December 5, 2003; 278(49): 49145 - 49153.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
A. Dunne and L. A. J. O'Neill
The Interleukin-1 Receptor/Toll-Like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense
Sci. Signal., February 25, 2003; 2003(171): re3 - re3.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.